What Are the Key Components of Preclinical Studies in Nanotechnology?
Preclinical studies in nanotechnology typically include:
1. In vitro studies: Laboratory-based tests to evaluate the interaction of nanoparticles with cells and tissues. 2. In vivo studies: Animal studies to assess the safety, biodistribution, and therapeutic efficacy. 3. Toxicology testing: Determining the potential toxic effects of nanoparticles on living organisms. 4. Pharmacokinetics and pharmacodynamics: Studying the absorption, distribution, metabolism, and excretion (ADME) of nanoparticles.
